Skip to main content

Park Ha Biological Technology Co., Ltd.

Qualité des données : 100%
BYAH
Nasdaq Manufacturing Chemicals
1,04 €
▼ 0,01 € (-0,95%)
Cap. Boursière: 3,38 M
Prix
1,05 €
Cap. Boursière
3,38 M
Fourchette du Jour
Fourchette 52 Semaines
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

Quick Summary

Points Clés

Earnings declined -5191,25% over the past year
Generating 85 852,0 in free cash flow

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)6,00%
Earnings (1Y)-5191,25%
FCF Growth (3Y)N/A

Qualité

Return on Equity
-885,84%
En dessous de la moyenne du secteur (-53,47%)
ROIC-677,76%
Net Margin-965,00%
Op. Margin-956,45%

Sécurité

Debt / Equity
N/A
Current Ratio3,68
Interest Coverage-588997,59

Valorisation

PE (TTM)
-0,14
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,80
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -1,5
P/B 0,8 1,6
ROE % -885,8 -53,5
Net Margin % -965,0 -41,5
Rev Growth 5Y % 1,8
D/E 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 2,68 M

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) -5191,25% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,52 M Net Income (TTM) -24,36 M
ROE -885,84% ROA -539,29%
Gross Margin 94,36% Operating Margin -956,45%
Net Margin -965,00% Free Cash Flow (TTM) 85 852,0
ROIC -677,76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,68
Interest Coverage -588997,59 Asset Turnover 0,56
Working Capital 4,07 M Tangible Book Value 4,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,14 Forward P/E N/A
P/B Ratio 0,80 P/S Ratio 1,34
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 2,54%
Market Cap 3,38 M Enterprise Value 3,38 M
Per Share
EPS (Diluted TTM) -41,38 Revenue / Share 0,78
FCF / Share 0,03 OCF / Share 0,03
EPS CAGR (1Y) -207000,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -0,35%
SBC-Adj. FCF -23,98 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 2,52 M 2,38 M
Net Income -24,36 M 478 561,0
EPS (Diluted) -41,38 0,02
Gross Profit 2,38 M 2,19 M
Operating Income -24,15 M 793 714,0
EBITDA
R&D Expenses 238 184,0 36 714,0
SG&A Expenses
D&A 109 369,0 22 686,0
Interest Expense 41,0 194,0
Income Tax 280 646,0 314 860,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 5,95 M 3,08 M
Total Liabilities 1,96 M 1,58 M
Shareholders' Equity 3,99 M 1,51 M
Total Debt
Cash & Equivalents 3,79 M 547 498,0
Current Assets 5,50 M 2,84 M
Current Liabilities 1,88 M 1,52 M